These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8539417)
21. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434. Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457 [TBL] [Abstract][Full Text] [Related]
22. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574 [TBL] [Abstract][Full Text] [Related]
23. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Huang KX; Bergstrom DA; Ruskin DN; Walters JR Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877 [TBL] [Abstract][Full Text] [Related]
24. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Subramaniam S; Lucki I; McGonigle P Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781 [TBL] [Abstract][Full Text] [Related]
25. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding. Engber TM; Marin C; Susel Z; Chase TN Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970 [TBL] [Abstract][Full Text] [Related]
26. Imipramine and fluoxetine prevent the stress-induced escape deficits in rats through a distinct mechanism of action. Gambarana C; Ghiglieri O; Taddei I; Tagliamonte A; De Montis MG Behav Pharmacol; 1995 Jan; 6(1):66-73. PubMed ID: 11224313 [TBL] [Abstract][Full Text] [Related]
27. D1 dopamine receptor stimulation inhibits firing activity of midbrain dopamine neurons in reserpine treated rats: an effect eliminated after hemitransection of diencephalon. Sun BC; Chouvet G; Jin GZ Synapse; 1996 Sep; 24(1):29-38. PubMed ID: 9046074 [TBL] [Abstract][Full Text] [Related]
28. Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm. Besson A; Privat AM; Eschalier A; Fialip J Pharmacol Biochem Behav; 1999 Nov; 64(3):541-8. PubMed ID: 10548269 [TBL] [Abstract][Full Text] [Related]
29. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants. Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237 [TBL] [Abstract][Full Text] [Related]
30. Antidepressant-like effects of the subtype-selective nicotinic acetylcholine receptor agonist, SIB-1508Y, in the learned helplessness rat model of depression. Ferguson SM; Brodkin JD; Lloyd GK; Menzaghi F Psychopharmacology (Berl); 2000 Oct; 152(3):295-303. PubMed ID: 11105940 [TBL] [Abstract][Full Text] [Related]
31. Animal models for the study of antidepressant activity. Gambarana C; Scheggi S; Tagliamonte A; Tolu P; De Montis MG Brain Res Brain Res Protoc; 2001 Apr; 7(1):11-20. PubMed ID: 11275519 [TBL] [Abstract][Full Text] [Related]
32. A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study. Gambarana C; Masi F; Tagliamonte A; Scheggi S; Ghiglieri O; De Montis MG J Neurochem; 1999 May; 72(5):2039-46. PubMed ID: 10217282 [TBL] [Abstract][Full Text] [Related]
33. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Itoh T; Tokumura M; Abe K Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987 [TBL] [Abstract][Full Text] [Related]
34. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors. Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182 [TBL] [Abstract][Full Text] [Related]
35. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity. Paul ML; Currie RW; Robertson HA Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877 [TBL] [Abstract][Full Text] [Related]
36. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output. Huang KX; Walters JR J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456 [TBL] [Abstract][Full Text] [Related]
37. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. LaHoste GJ; Yu J; Marshall JF Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797 [TBL] [Abstract][Full Text] [Related]